bioRxivCancer BiologyPreprint
The cell cycle state defines TACC3 as a regulator gene in glioblastoma
H. Briggs, E. Polson, B. K. Irving, A. Zougman, R. K. Mathew, D. M. Gendoo, H. Wurdak
Abstract
Overexpression and mitosis-promoting roles of Transforming acidic coiled-coil containing protein 3 (TACC3) are well-established in many cancers, including glioblastoma (GBM). However, the effector gene networks downstream of TACC3 remain poorly defined, partly due to an incomplete understanding of TACC3 cell lineage specificity and its dynamic role during the cell cycle. Here, we use a patient-derived GBM model to report that TACC3 predominantly resides in the GBM cell cytoplasm, while engaging in gene regulation temporally as defined by the cell cycle state. TACC3 loss-of-function, cell cycle stage-specific transcriptomics, and unsupervised self-organizing feature maps revealed pathways (including Hedgehog signalling) and individual genes (including HOTAIR) that exhibited anticorrelated expression phenotypes across interphase and mitosis. Furthermore, this approach identified a set of 22 TACC3-dependent transcripts in publicly-available clinical databases that predicted poor overall and progression-free survival in 162 GBM and 514 low-grade glioma patient samples. These findings uncover TACC3-dependent genes as a function of TACC3 cell cycle oscillation, which is important for TACC3-targeting strategies, and for predicting poor outcomes in brain cancer patients.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
O. Saatci, O. Akbulut, … O. Sahin·bioRxiv·May 18, 2022
- Morphoregulatory ADD3 underlies glioblastoma growth and formation of tumor-tumor connections
Carlotta Barelli, Flaminia Kaluthantrige Don, … Nereo Kalebic·Life Science AlliancePeer-reviewed·Nov 26, 2024
- CDK12/CDK13 inhibition disrupts a transcriptional program critical for glioblastoma survival
S. Lier, S. O. Lund, … D. P. Pandey·bioRxiv·Jul 14, 2023
- VERY LONG-CHAIN ACYL-CoA SYNTHETASE-3 (ACSVL3) PROMOTES THE MALIGNANT GROWTH BEHAVIOR OF U87 GLIOMA CELLS VIA CHANGES IN CELL CYCLE WITHOUT AFFECTING APOPTOSIS
H. Yang, X. Shi, … P. A. Watkins·bioRxiv·May 4, 2023
- ASCL1 regulates neurodevelopmental transcription factors and cell cycle genes in glioblastoma
T. Y. Vue, R. Kollipara, … J. E. Johnson·bioRxiv·Feb 20, 2020
- METTL3 modulates cell viability and motility in HCC1143 and MDA-MB-231 triple-negative breast cancer cells
Buket Sağlam, Azime Akçaöz-Alasar, … Bünyamin Akgül·bioRxiv·Jul 20, 2026